Randomized controlled trials in surgical resection of colorectal peritoneal metastases: Disentangling negativity in PRODIGE 7 and PROPHYLOCHIP
- 22 February 2021
- journal article
- editorial
- Published by Wiley in Colorectal Disease
- Vol. 23 (6), 1303-1305
- https://doi.org/10.1111/codi.15596
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trialThe Lancet Oncology, 2021
- Colorectal liver metastases: Current management and future perspectivesWorld Journal of Clinical Oncology, 2020
- Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP–PRODIGE 15): a randomised, phase 3 studyThe Lancet Oncology, 2020
- Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trialTrials, 2019
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian CancerThe New England Journal of Medicine, 2018
- Treatment of surgically resectable colorectal peritoneal metastasesBritish Journal of Surgery, 2013
- Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French StudyJournal of Clinical Oncology, 2010
- Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal CancerJournal of Clinical Oncology, 2003
- Surgical research or comic opera: questions, but few answersThe Lancet, 1996
- Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosisPublished by Springer Science and Business Media LLC ,1996